High Falls Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
High Falls Advisors's LLY Position: Q4 2025 in Review
High Falls Advisors reduced its Eli Lilly (LLY) stake by 7.8% in Q4 2025, selling an estimated $45.9K and leaving 565 shares worth $607K. The position accounts for 0.12% of the portfolio, ranked #55.
High Falls Advisors first reported a position in LLY in Q1 2021 and has held it in 9 quarters since. 4,428 funds tracked by Wall St. Rank hold LLY as of Q4 2025.
- High Falls Advisors held 565 shares of Eli Lilly worth $607K as of Q4 2025.
- High Falls Advisors sold 48 Eli Lilly shares in Q4 2025, an estimated $45.9K.
- Eli Lilly made up 0.12% of High Falls Advisors's portfolio in Q4 2025, its #55 holding.
- High Falls Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 9 quarters since.
- 4,428 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.
Based on High Falls Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.